期刊文献+

胆红素、血脂及Chemerin水平对冠心病患者病情进展的影响 被引量:4

Effects of bilirubin,blood lipid and Chemerin level on the progression of patients with coronary heart disease
下载PDF
导出
摘要 目的探讨胆红素、血脂及Chemerin水平对冠心病患者病情进展的影响。方法选择冠心病患者157例,分为单支病变组(A组)、双支病变组(B组)、多支病变组(C组),分别为61、52、44例。分别检测血胆红素及血脂、Chemerin水平。结果 B组IBIL、DBIL、TBIL及Chemerin较A组均有显著性差异(P<0.05);C组IBIL、TBIL及Chemerin较A、B组有显著性差异(P<0.05);DBIL较A组均有显著性差异(P<0.05)。B组TG、TC、HDL、LDL较A组均有显著性差异(P<0.05);C组TC、LDL较A、B组有显著性差异(P<0.05);TG、HDL较A组均有显著性差异(P<0.05)。IBIL与TC、LDL、Chemerin呈显著负相关(P<0.05),DBIL与Chemerin呈显著负相关(P<0.05),TBIL与TC、LDL、Chemerin呈显著负相关(P<0.05)。结论胆红素代谢异常与血脂代谢及脂肪因子紊乱密切相关,是导致冠状动脉粥样硬化的重要因素。 Objective To investigate effects of bilirubin,blood lipid and Chemerin level on the progression of patients with coronary heart disease.Methods 157 cases of coronary heart disease patients were choosen and divided into single lesion group (group A)and double branch lesion group (group B),multivessel lesions group (group C),there are respectively 61 patients,52 cases,44 cases.Blood bilirubin and blood lipid,Chemerin level were detected respectively.Results IBIL,DBIL,TBIL and Chemerin of group B than group A were significant difference (P〈0.05),IBIL,TBIL and Chemerin of group C are significant different than the A and B group (P〈0.05),DBIL were significant different from group A (P〈0.05).TG,TC,HDL and LDL of group B than group A were significant different (P〈0.05),TC,LDL of C group had significant difference than the A and B group (P〈0.05),TG,HDL of group A showed significant difference (P〈0.05).IBIL and TC,LDL,Chemerin showed significant negative correlation (P〈0.05),DBIL and Chemerin showed significant negative correlation (P〈0.05), TBIL and TC,LDL,Chemerin showed significant negative correlation (P〈0.05).Conclusion Bilirubin metab-olism and blood lipid metabolism and fat factor disorders are closely related,which are of the important factors lead-ing to coronary atherosclerosis.
作者 刘凡
出处 《国外医学(医学地理分册)》 CAS 2014年第3期230-232,共3页 Foreign Medical Sciences:Section of Medgeography
关键词 冠心病 胆红素 血脂 Chemerin coronary heart disease bilirubin blood lipid chemerin
  • 相关文献

参考文献13

  • 1张玉涛,康龙丽.70~99岁老人冠状动脉钙、颈动脉壁厚度与心血管病的关系[J].国外医学(医学地理分册),2012,33(4):273-275. 被引量:5
  • 2Demir M, Demir C, Cosar S. The relationship between serum bilirubin concentration and coronary slow flow[J]. Ther Adv Cardiovasc Dis,2013,7(6) :316-321.
  • 3Sathiya R, Velu VK, Niranjan G, et al. A Comparative Study of Serum Uric Acid levels and Lipid Ratios in Coronary Artery Disease Patients[J]. Int J Biomed Sci,2014,10(2) : 124-128.
  • 4Tennyson C, Lee R, Attia R. Is there a role for HbAlc in pre- dicting mortality and morbidity outcomes after coronary artery bypass graft surgery? [J]. Interact Cardiovasc Thorac Surg, 2013,17(6) : 1000-1008.
  • 5杨宇轩,王亚峰,徐兴科,吴朝飞,张献伟,周锐,于燕.西安市某社区的社区诊断模式及应对策略[J].国外医学(医学地理分册),2013,34(2):106-112. 被引量:18
  • 6Kang SJ, Kim D, Park HE, et al. Elevated serum bilirubin lev- els are inversely associated with coronary artery atherosclerosis [J]. Atherosclerosis,2013,230(2) :242-248.
  • 7Sung KC, Shin J, Lim YH, et al. Relation of conjugated biliru- bin concentrations to the presence of coronary artery calcium [J]. Am J Cardiol,2013,112(12) :1873-1879.
  • 8Erkan A, Ekici B, Ugurlu M, et al. The role of bilirubin and its protective function against coronary heart disease[J]. Herz, 2013,18(3) : 173-189.
  • 9Nagata I, Ike A, Nishikawa H, et al. Associations between lip- id profiles and MACE in hemodialysis patients with percutane- ous coronary intervention: From the FU-Registry[J]. J Cardi- ol,2014,41(1) :73-79.
  • 10Assari S, Ahmadi K, Kazemi SD. Gender Differences in the Association between Lipid Profile and Sexual Function among Patients with Coronary Artery Disease[J]. Int Cardiovasc Res J,2014,8(1) :9-14.

二级参考文献19

共引文献20

同被引文献36

  • 1Farkas CA. Potentially harmful side-effects: medically unexplained symptoms, somatization, and the insufficient illness narrative for view- ers of mystery diagnosis [ J ]. J Med Humanit, 2013,34 ( 3 ) : 315-328.
  • 2Dobbin A, Dobbin J, Ross SC, et al. Randomised controlled trial of brief intervention with biofeedback and hypnotherapy in patients with refractory irritable bowel syndrome [ J ]. J R Coll Physicians Edinb, 2013,43 ( 1 ) : 15-23.
  • 3Lara-Vega HP.Mononucleosis infecciosa[J].Revista Medica de Costa Rica,2009,587:73–77.
  • 4Gao LW,Xie ZD,Liu YY,et al.Epidemiologic and clinical characteristics of infectious mononucleosis associated with Epstein-Barr virus infection in children in Beijing,China[J].World J Pediatr,2011,7(1):45–49.
  • 5González S,Monroy Colín VA,Pina Ruiz G,et al.Clinical and laboratory characteristics of infectious mononucleosis by Epstein-Barr virus in Mexican children[J].BMC Res Notes,2012,5:361-363.
  • 6Chovel-Sella A,Ben Tov A,Lahav E,et al.Incidence of rash after Amoxicillin treatment in children with infectious mononucleosis[J].Pediatrics,2013,131(5):1424-1427.
  • 7Rostgaard K,Wohlfahrt J,Hjalgrim H.A genetic basis for infectious mononucleosis:evidence from a family study of hospitalized cases in denmark[J].Clin Infect Dis,2014,58(12):1684-1689.
  • 8Wang Y,Li J,Ren YY,et al.The levels of liver enzymes and atypical lymphocytes are higher in youth patients with infectious mononucleosis than in preschool children[J].Clin Mol Hepatol,2013,19(4):382-388.
  • 9Odumade OA,Hogquist KA,Blafour HH Jr.Progress and problems in understanding and managing primary Epstein-Barr virus infections[J].Clin Microbiol Rev,2011,24(1):193–209.
  • 10Luzuriaga K,Sullivan JL.Infectious mononucleosis[J].New Eng J Med,2010,362(21):1993–2000.

引证文献4

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部